A novel chimeric dengue vaccine candidate composed of consensus envelope protein domain III fused to C-terminal-modified NS1 protein.
Huang HJ, Yang M, Chen HW, Wang S, Chang CP, Ho TS, Kao YS, Tien SM, Lin HH, Chang PC, Lai YC, Hsiao YP, Liu YL, Chao CH, Anderson R, Yeh TM, Lin YS, Wan SW.
Huang HJ, et al. Among authors: lin hh, lin ys.
Vaccine. 2022 Apr 1;40(15):2299-2310. doi: 10.1016/j.vaccine.2022.02.070. Epub 2022 Mar 11.
Vaccine. 2022.
PMID: 35287985